200 related articles for article (PubMed ID: 6541026)
1. Diurnal variation in blood 17-hydroxyprogesterone concentrations in untreated congenital adrenal hyperplasia.
Sólyom J
Arch Dis Child; 1984 Aug; 59(8):743-7. PubMed ID: 6541026
[TBL] [Abstract][Full Text] [Related]
2. Age of appearance of circadian rhythm in blood 17-hydroxyprogesterone in 21-hydroxylase deficiency.
Sólyom J
Acta Physiol Hung; 1991; 78(2):107-10. PubMed ID: 1808976
[TBL] [Abstract][Full Text] [Related]
3. Blood-spot 17-hydroxyprogesterone daily profiles in infants with congenital adrenal hyperplasia.
Sólyom J; Hosszu E; Gács G
Exp Clin Endocrinol; 1990 Sep; 96(1):52-6. PubMed ID: 2279525
[TBL] [Abstract][Full Text] [Related]
4. [Plasmatic 17-alpha-hydroxyprogesterone in congenital adrenal hyperplasia due to 21 hydroxylase deficiency, treated and untreated].
Loras B; Roux H; Audi-Parera L; David M; Bertrand J
Biomedicine; 1974 Jul; 21(7):317-22. PubMed ID: 4373095
[No Abstract] [Full Text] [Related]
5. The hypothalamic-pituitary-adrenal axis in partial (late-onset) 21-hydroxylase deficiency.
Feuillan P; Pang S; Schürmeyer T; Avgerinos PC; Chrousos GP
J Clin Endocrinol Metab; 1988 Jul; 67(1):154-60. PubMed ID: 2837498
[TBL] [Abstract][Full Text] [Related]
6. 17-Hydroxyprogesterone rhythms and growth velocity in congenital adrenal hyperplasia.
Pincus DR; Kelnar CJ; Wallace AM
J Paediatr Child Health; 1993 Aug; 29(4):302-4. PubMed ID: 8373678
[TBL] [Abstract][Full Text] [Related]
7. 3 alpha-androstanediol glucuronide in virilizing congenital adrenal hyperplasia: a useful serum metabolic marker of integrated adrenal androgen secretion.
Pang S; MacGillivray M; Wang M; Jeffries S; Clark A; Rosenthal I; Wiegensberg M; Riddick L
J Clin Endocrinol Metab; 1991 Jul; 73(1):166-74. PubMed ID: 2045467
[TBL] [Abstract][Full Text] [Related]
8. [Diurnal rhythm of plasma 17-hydroxyprogesterone unter everyday conditions in children with congenital, virilizing adrenal gland hyperplasia].
von Petrykowski W; Kreuzer HB
Monatsschr Kinderheilkd (1902); 1976 May; 124(5):391-3. PubMed ID: 945449
[No Abstract] [Full Text] [Related]
9. [Radioimmunoassay of salivary l7 alpha-hydroxyprogesterone. Values obtained in healthy subjects and in patients treated for congenital hyperplasia of the adrenal glands].
Guechot J; Fiet J; Gourmelen M; Pham-Huu-Trung MT; Raux-Eurin MC; Brerault JL; Gueux B; Villette JM
Ann Biol Clin (Paris); 1985; 43(4):333-7. PubMed ID: 4091295
[TBL] [Abstract][Full Text] [Related]
10. Serum melatonin is not affected by glucocorticoid replacement in congenital adrenal hyperplasia.
Waldhauser F; Frisch H; Krautgasser-Gasparotti A; Schober E; Bieglmayer C
Acta Endocrinol (Copenh); 1986 Mar; 111(3):355-9. PubMed ID: 3962565
[TBL] [Abstract][Full Text] [Related]
11. Plasma 17 alpha-hydroxyprogesterone and aldosterone concentrations in infants and children with congenital adrenal hyperplasia--the role of salt-losing hormones in salt wasting.
Holcombe JH; Keenan BS; Clayton GW
J Pediatr; 1981 Apr; 98(4):573-5. PubMed ID: 7205484
[No Abstract] [Full Text] [Related]
12. Circadian variation in plasma 17-hydroxyprogesterone in patients with congenital adrenal hyperplasia.
Atherden SM; Barnes ND; Grant DB
Arch Dis Child; 1972 Aug; 47(254):602-4. PubMed ID: 5046776
[TBL] [Abstract][Full Text] [Related]
13. [Determination of urinary 17 alpha-hydroxyprogesterone excretion using ELISA--evaluation of normal subjects and patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency].
Shibata Y
Nihon Naibunpi Gakkai Zasshi; 1991 Aug; 67(8):819-39. PubMed ID: 1813324
[TBL] [Abstract][Full Text] [Related]
14. Studies on the diurnal variations of 17-hydroxyprogesterone in saliva by enzyme immunoassay in patients with congenital adrenal hyperplasia.
Hoepffner W; Hubl W
Exp Clin Endocrinol; 1986 Jul; 87(2):189-94. PubMed ID: 3530788
[TBL] [Abstract][Full Text] [Related]
15. Blood-spot 17 alpha-hydroxyprogesterone radioimmunoassay in the follow-up of congenital adrenal hyperplasia.
Sólyom J
Clin Endocrinol (Oxf); 1981 Jun; 14(6):547-53. PubMed ID: 7296904
[TBL] [Abstract][Full Text] [Related]
16. Value of selective screening for congenital adrenal hyperplasia in Hungary.
Sólyom J; Hughes IA
Arch Dis Child; 1989 Mar; 64(3):338-42. PubMed ID: 2705794
[TBL] [Abstract][Full Text] [Related]
17. Early diagnosis of congenital adrenal hyperplasia by measurement of 17-hydroxyprogesterone.
Youssefnejadian E; David R
Clin Endocrinol (Oxf); 1975 Jul; 4(4):451-54. PubMed ID: 168994
[TBL] [Abstract][Full Text] [Related]
18. 17OH-progesterone response to acute dexamethasone administration in congenital adrenal hyperplasia.
Shen SX; Young MC; Hinohosa-Sandoval M; Hughes IA
Horm Res; 1989; 32(4):136-41. PubMed ID: 2625323
[TBL] [Abstract][Full Text] [Related]
19. Pituitary-adrenal axis activity in treated congenital adrenal hyperplasia: static and dynamic studies.
Pham-Huu-Trung MT; Gourmelen M; Raux-Eurin MC; Girard F
J Clin Endocrinol Metab; 1978 Aug; 47(2):422-7. PubMed ID: 233672
[TBL] [Abstract][Full Text] [Related]
20. Congenital adrenal hyperplasia family studies using the short ACTH test.
Kreutzmann DJ; Cowell CT; Howard NJ; De Souza M; Silink M
Aust Paediatr J; 1989 Dec; 25(6):340-5. PubMed ID: 2619637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
